Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 269

1.

CXCR4 expression on circulating pan-cytokeratin positive cells is associated with survival in patients with advanced non-small cell lung cancer.

Reckamp KL, Figlin RA, Burdick MD, Dubinett SM, Elashoff RM, Strieter RM.

BMC Cancer. 2009 Jun 29;9:213. doi: 10.1186/1471-2407-9-213.

2.

CXCL12-binding receptors expression in non-small cell lung cancer relates to tumoral microvascular density and CXCR4 positive circulating tumoral cells in lung draining venous blood.

Franco R, Pirozzi G, Scala S, Cantile M, Scognamiglio G, Camerlingo R, Botti G, Rocco G.

Eur J Cardiothorac Surg. 2012 Feb;41(2):368-75. doi: 10.1016/j.ejcts.2011.05.009. Epub 2011 Dec 12.

PMID:
21683606
3.

Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) detection in cancer patients: a prognostic marker for lung metastases from solid malignancies.

Karapanagiotou EM, Pelekanou E, Charpidou A, Tsaganos T, Anagnostou V, Plachouras D, Giamarellos-Bourboulis EJ, Syrigos KN.

Anticancer Res. 2008 Mar-Apr;28(2B):1411-5.

4.

Expression and prognostic significance of cyclin B1 and cyclin A in non-small cell lung cancer.

Cooper WA, Kohonen-Corish MR, McCaughan B, Kennedy C, Sutherland RL, Lee CS.

Histopathology. 2009 Jul;55(1):28-36. doi: 10.1111/j.1365-2559.2009.03331.x.

PMID:
19614764
5.

S100A2 induces metastasis in non-small cell lung cancer.

Bulk E, Sargin B, Krug U, Hascher A, Jun Y, Knop M, Kerkhoff C, Gerke V, Liersch R, Mesters RM, Hotfilder M, Marra A, Koschmieder S, Dugas M, Berdel WE, Serve H, Müller-Tidow C.

Clin Cancer Res. 2009 Jan 1;15(1):22-9. doi: 10.1158/1078-0432.CCR-08-0953.

6.

Basic fibroblast growth factor-2/beta3 integrin expression profile: signature of local progression after chemoradiotherapy for patients with locally advanced non-small-cell lung cancer.

Massabeau C, Rouquette I, Lauwers-Cances V, Mazières J, Bachaud JM, Armand JP, Delisle MB, Favre G, Toulas C, Cohen-Jonathan-Moyal E.

Int J Radiat Oncol Biol Phys. 2009 Nov 1;75(3):696-702. doi: 10.1016/j.ijrobp.2008.11.050. Epub 2009 Apr 20.

PMID:
19386436
7.

CXCR4 expression in early breast cancer and risk of distant recurrence.

Andre F, Xia W, Conforti R, Wei Y, Boulet T, Tomasic G, Spielmann M, Zoubir M, Berrada N, Arriagada R, Hortobagyi GN, Hung MC, Pusztai L, Delaloge S, Michiels S, Cristofanilli M.

Oncologist. 2009 Dec;14(12):1182-8. doi: 10.1634/theoncologist.2009-0161. Epub 2009 Nov 25.

8.

CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: analysis within a group of patients, all of whom developed lung metastasis.

Oda Y, Yamamoto H, Tamiya S, Matsuda S, Tanaka K, Yokoyama R, Iwamoto Y, Tsuneyoshi M.

Mod Pathol. 2006 May;19(5):738-45.

9.

Cytoplasmic CXCR4 expression in breast cancer: induction by nitric oxide and correlation with lymph node metastasis and poor prognosis.

Yasuoka H, Tsujimoto M, Yoshidome K, Nakahara M, Kodama R, Sanke T, Nakamura Y.

BMC Cancer. 2008 Nov 23;8:340. doi: 10.1186/1471-2407-8-340.

10.
11.

Up-regulation of survivin mRNA might be a marker for non-invasive detection of non-small cell lung cancer rather than for prognosis.

Warnecke-Eberz U, Baldus SE, Bollschweiler E, Hoelscher AH, Metzger R.

Anticancer Res. 2008 May-Jun;28(3A):1525-9.

12.

Breast cancer metastasis suppressor 1 inhibits SDF-1alpha-induced migration of non-small cell lung cancer by decreasing CXCR4 expression.

Yang J, Zhang B, Lin Y, Yang Y, Liu X, Lu F.

Cancer Lett. 2008 Sep 28;269(1):46-56. doi: 10.1016/j.canlet.2008.04.016. Epub 2008 May 23.

PMID:
18502034
13.

Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma.

Sasaki K, Natsugoe S, Ishigami S, Matsumoto M, Okumura H, Setoyama T, Uchikado Y, Kita Y, Tamotsu K, Hanazono K, Owaki T, Aikou T.

Oncol Rep. 2009 Jan;21(1):65-71.

PMID:
19082444
14.

Nuclear and cytoplasmic death receptor 5 as prognostic factors in patients with non-small cell lung cancer treated with chemotherapy.

Leithner K, Stacher E, Wurm R, Ploner F, Quehenberger F, Wohlkoenig C, Bálint Z, Polachova J, Olschewski A, Samonigg H, Popper HH, Olschewski H.

Lung Cancer. 2009 Jul;65(1):98-104. doi: 10.1016/j.lungcan.2008.10.015. Epub 2008 Dec 9.

PMID:
19081160
15.

Prognostic significance of pre B cell leukemia transcription factor 2 (PBX2) expression in non-small cell lung carcinoma.

Qiu Y, Morii E, Tomita Y, Zhang B, Matsumura A, Kitaichi M, Okumura M, Aozasa K.

Cancer Sci. 2009 Jul;100(7):1198-209. doi: 10.1111/j.1349-7006.2009.01156.x. Epub 2009 Mar 12.

16.

CC ligand 2 levels are increased in LPS-stimulated peripheral monocytes of patients with non-small cell lung cancer.

Miotto D, Boschetto P, Bononi I, Milani G, Legorini C, Cavallesco G, Lo Cascio N, Zeni E, Fabbri LM, Mapp CE.

Respir Med. 2007 Aug;101(8):1738-43. Epub 2007 Apr 12.

17.

Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.

Paci M, Maramotti S, Bellesia E, Formisano D, Albertazzi L, Ricchetti T, Ferrari G, Annessi V, Lasagni D, Carbonelli C, De Franco S, Brini M, Sgarbi G, Lodi R.

Lung Cancer. 2009 Apr;64(1):92-7. doi: 10.1016/j.lungcan.2008.07.012. Epub 2008 Sep 19.

PMID:
18804892
18.

Clinical significance of CXC chemokine receptor-4 and c-Met in childhood rhabdomyosarcoma.

Diomedi-Camassei F, McDowell HP, De Ioris MA, Uccini S, Altavista P, Raschellà G, Vitali R, Mannarino O, De Sio L, Cozzi DA, Donfrancesco A, Inserra A, Callea F, Dominici C.

Clin Cancer Res. 2008 Jul 1;14(13):4119-27. doi: 10.1158/1078-0432.CCR-07-4446.

19.

L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer.

Imai H, Kaira K, Oriuchi N, Yanagitani N, Sunaga N, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M.

Histopathology. 2009 Jun;54(7):804-13. doi: 10.1111/j.1365-2559.2009.03300.x.

PMID:
19635099
20.

Three immunomarker support vector machines-based prognostic classifiers for stage IB non-small-cell lung cancer.

Zhu ZH, Sun BY, Ma Y, Shao JY, Long H, Zhang X, Fu JH, Zhang LJ, Su XD, Wu QL, Ling P, Chen M, Xie ZM, Hu Y, Rong TH.

J Clin Oncol. 2009 Mar 1;27(7):1091-9. doi: 10.1200/JCO.2008.16.6991. Epub 2009 Feb 2.

PMID:
19188679

Supplemental Content

Support Center